Federal “right-to-try” legislation was passed and signed into law by President Trump over a year ago. Advocates promised that lots of terminally ill people who were dying then would be saved by having the right to “try” experimental therapies outside of the context of clinical trials. That has not happened. This should come as no surprise, because right-to-try was never about getting experimental drugs to dying patients. It was always about weakening the FDA and making money.
Search: “Stanislaw Burzynski glioblastoma”
We found 23 results for your search.
Orac has finally located the abstract published by Dr. Alberto Siller and Alberto Garcia, who are selling intra-arterial chemotherapy for the deadly brain tumor DIPG. Let’s just say that he’s…less than impressed by the results. Shades of Burzynski!
Share this:
Rigvir is a “virotherapy” from Latvia promoted by the International Virotherapy Center and, increasingly, by alternative cancer clinics. There is no convincing scientific evidence for its efficacy. That didn’t stop its advocates from presenting a case report. Not surprisingly, the case report isn’t convincing either.
Share this:
I’ve been following Mike Adams a long time, going back to 2007 and even before. It’s difficult to find anyone who can pack more pseudoscience, conspiracy mongering, and outright hateful bile into an article when he has a mind to do so. I’ve documented this tendency many times, so many times that, each time I […]
Share this:
If this looks a bit familiar to some of you, let’s just say that it’s grant crunch time again. This should be over after today. I hope. In the meantime, one of the difficult things about science-based medicine is determining what is and isn’t quackery. While it is quite obvious that modalities such as homeopathy, […]
